25 related articles for article (PubMed ID: 12127523)
1. Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cells.
Karpova D; Rettig MP; Ritchey J; Cancilla D; Christ S; Gehrs L; Chendamarai E; Evbuomwan MO; Holt M; Zhang J; Abou-Ezzi G; Celik H; Wiercinska E; Yang W; Gao F; Eissenberg LG; Heier RF; Arnett SD; Meyers MJ; Prinsen MJ; Griggs DW; Trumpp A; Ruminski PG; Morrow DM; Bonig HB; Link DC; DiPersio JF
J Clin Invest; 2019 May; 129(7):2745-2759. PubMed ID: 31085833
[TBL] [Abstract][Full Text] [Related]
2. N-Tetrahydrofuroyl-(L)-phenylalanine derivatives as potent VLA-4 antagonists.
Yang GX; Chang LL; Truong Q; Doherty GA; Magriotis PA; de Laszlo SE; Li B; MacCoss M; Kidambi U; Egger LA; McCauley E; Van Riper G; Mumford RA; Schmidt JA; Hagmann WK
Bioorg Med Chem Lett; 2002 Jun; 12(11):1497-500. PubMed ID: 12031328
[TBL] [Abstract][Full Text] [Related]
3. Dehydrophenylalanine derivatives as VLA-4 integrin antagonists.
Porter JR; Archibald SC; Brown JA; Childs K; Critchley D; Head JC; Parton TA; Robinson MK; Shock A; Taylor RJ; Warrellow GJ
Bioorg Med Chem Lett; 2003 Mar; 13(5):805-8. PubMed ID: 12617895
[TBL] [Abstract][Full Text] [Related]
4. Substituted tetrahydrofuroyl-1-phenylalanine derivatives as potent and specific VLA-4 antagonists.
Doherty GA; Yang GX; Borges E; Chang LL; MacCoss M; Tong S; Kidambi U; Egger LA; McCauley E; Van Riper G; Mumford RA; Schmidt JA; Hagmann WK
Bioorg Med Chem Lett; 2002 Jun; 12(11):1501-5. PubMed ID: 12031329
[TBL] [Abstract][Full Text] [Related]
5. N-(3-phenylsulfonyl-3-piperidinoyl)-phenylalanine derivatives as potent, selective VLA-4 antagonists.
Gutteridge CE; de Laszlo SE; Kamenecka TM; McCauley E; van Riper G; Mumford RA; Kidambi U; Egger LA; Tong S; Hagmann WK
Bioorg Med Chem Lett; 2003 Mar; 13(5):885-90. PubMed ID: 12617914
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and SAR of N-benzoyl-L-biphenylalanine derivatives: discovery of TR-14035, a dual alpha(4)beta(7)/alpha(4)beta(1) integrin antagonist.
Sircar I; Gudmundsson KS; Martin R; Liang J; Nomura S; Jayakumar H; Teegarden BR; Nowlin DM; Cardarelli PM; Mah JR; Connell S; Griffith RC; Lazarides E
Bioorg Med Chem; 2002 Jun; 10(6):2051-66. PubMed ID: 11937364
[TBL] [Abstract][Full Text] [Related]
7. N-(arylacetyl)-biphenylalanines as potent VLA-4 antagonists.
Li B; de Laszlo SE; Kamenecka TM; Kopka IE; Durette PL; Lanza T; MacCoss M; Tong S; Mumford RA; McCauley ED; Van Riper G; Schmidt JA; Hagmann WK
Bioorg Med Chem Lett; 2002 Aug; 12(16):2141-4. PubMed ID: 12127523
[TBL] [Abstract][Full Text] [Related]
8. The discovery of VLA-4 antagonists.
Tilley JW; Chen L; Sidduri A; Fotouhi N
Curr Top Med Chem; 2004; 4(14):1509-23. PubMed ID: 15544541
[TBL] [Abstract][Full Text] [Related]
9. The discovery and potential of N-sulfonylated dipeptide VLA-4 antagonists.
Hagmann WK
Curr Top Med Chem; 2004; 4(14):1461-71. PubMed ID: 15544537
[TBL] [Abstract][Full Text] [Related]
10. The identification and optimization of orally efficacious, small molecule VLA-4 antagonists.
Huryn DM; Konradi AW; Ashwell S; Freedman SB; Lombardo LJ; Pleiss MA; Thorsett ED; Yednock T; Kennedy JD
Curr Top Med Chem; 2004; 4(14):1473-84. PubMed ID: 15544538
[TBL] [Abstract][Full Text] [Related]
11. Rational design of potent and selective VLA-4 inhibitors and their utility in the treatment of asthma.
Singh J; Adams S; Carter MB; Cuervo H; Lee WC; Lobb RR; Pepinsky RB; Petter R; Scott D
Curr Top Med Chem; 2004; 4(14):1497-507. PubMed ID: 15544540
[TBL] [Abstract][Full Text] [Related]
12. VLA-4 antagonists: potent inhibitors of lymphocyte migration.
Yang GX; Hagmann WK
Med Res Rev; 2003 May; 23(3):369-92. PubMed ID: 12647315
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
